Purpose and objectives: Decrease in length of Post-Anesthesia Care Unit (PACU) recovery time has been linked to both patient satisfaction and reduced healthcare cost. This was a quality project which retrospectively reviewed patients` chart to assess recovery time whether administration of co-analgesics and sedatives in combination with propofol prolong recovery time. Primary outcome: PACU recovery time using the modified Aldrete scoring system. The ideal anesthetic for ambulatory cases should provide rapid and smooth emergence and recovery. Propofol is recently preferred short acting agent for gastrointestinal endoscopic procedures for induction, maintenance of anesthesia/deep sedation (1). The randomized controlled trials indicated that the potential benefits of propofol include a shorter recovery time, greater sedation, and improved patient cooperation (2). However, high dose of propofol may cause side effects and delay emergence. Study Design: This was a quality project which was retrospectively evaluating consecutive Gastroendoscopy cases at Parkland Hospital. Eligible subjects who received esophagogastroduodenoscopy (EGD) in 1 years’ period between 2014 to 2015. All patients in the review received propofol as their primary anesthetic, while some received additional co-analgesics and sedatives (midazolam, fentanyl, etomidate, ketamine, diphenhydramine). Recovery and PACU discharge time were compared between the propofol only groups versus the propofol plus adjuvant drug based on the modified Aldrete scoring system. Data was electronically collected in encrypted and password protected Excel file. At the end of the data collection, this Excel file was de-identified for the data analysis. Data was stored in secure encrypted research computer or secure research server and only research team will have access to electronic files. Retrospective analysis of consecutive patients undergoing esophagogastroduodenoscopy (EGD) at Parkland Hospital. The consecutive cases were evaluated for the Postoperative recovery time. The sample size of the project is the expected number of patients underwent EGD during 2014 to 2015.